![]() |
||||
|
Orchid Chemicals & Pharmaceuticals Ltd |
||||
|
Unaudited Financial Results for three months ended June
30, 2002
|
||||
| Sl No | Particulars |
Three Months Ended
30.06.2002 (Unaudited) |
Three Months Ended
30.06.2001 (Unaudited) |
Year Ended 31.03.2002
(Audited) |
|
1
|
Sales and Operating Income |
10683.50
|
8887.28
|
42552.48
|
|
2
|
Other Income |
2.60
|
1.94
|
75.32
|
|
3
|
Total Expenditure |
8477.70
|
6554.05
|
33365.74
|
| a) Decrease/(Increase) in Stock in trade |
(139.22)
|
(125.26)
|
(2266.84)
|
|
| b) Consumption of raw materials |
5570.54
|
4478.61
|
23514.95
|
|
| c) Staff Cost |
729.01
|
521.94
|
2506.10
|
|
| d) Other Expenditure |
2317.37
|
1678.76
|
9611.53
|
|
|
4
|
Gross Profit before Interest, Depreciation & Tax (1+2-3)
|
2208.40
|
2335.17
|
9262.06
|
|
5
|
Provision for doubtful debts
|
-
|
-
|
1195.43
|
|
6
|
Interest and Finance Charges |
756.62
|
789.04
|
3141.56
|
|
7
|
Depreciation |
1022.76
|
824.35
|
3582.15
|
|
8
|
Profit before tax (4-5-6-7) |
429.02
|
721.78
|
1342.92
|
|
9
|
Provision for Taxation |
|
||
| -Current Tax |
-
|
-
|
-
|
|
| -Deferred Tax |
138.27
|
170.09
|
712.30
|
|
|
10
|
Net Profit (8-9) |
290.75
|
551.69
|
630.62
|
|
11
|
Paid- up Equity Share Capital (Face value of Rs. 10 each) |
2799.92
|
2799.92
|
2799.92
|
|
12
|
Reserves excluding Revaluation Reserves |
|
30137.32
|
|
|
13
|
Basic & Diluted Earnings per Share (Rs.) |
1.04*
|
1.97*
|
2.25
|
| * EPS is for the period (not annualised) | ||||
| SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED | |||||
| Particulars |
Three Months Ended
30-06-02 |
Three Months Ended
30-06-01 |
Year Ended
31-03-02 |
||
| 1. Segment Revenue | |||||
| a. Bulk |
9724.73
|
8557.99
|
41273.30
|
||
| b. Formulations |
1186.51
|
466.86
|
2216.28
|
||
| Total |
10911.24
|
9024.85
|
43489.58
|
||
| Less: Inter segment revenue |
227.74
|
137.57
|
937.10
|
||
| Net Sales / Income from Operations |
10683.50
|
8887.28
|
42552.48
|
||
|
|
|||||
| 2. Segment Results |
|
||||
| a. Bulk |
1196.60
|
1659.35
|
5053.98
|
||
| b. Formulations |
(13.56)
|
(150.47)
|
(636.00)
|
||
| Total |
1183.04
|
1508.88
|
4417.98
|
||
| Less: |
|
||||
| i) Interest (Net) |
756.62
|
789.04
|
3141.56
|
||
| ii) Other unallocable expenditure net of unallocable income |
(2.60)
|
(1.94)
|
(66.50)
|
||
| Total Profit Before Tax |
429.02
|
721.78
|
1342.92
|
||
|
|
|||||
| 3. Capital Employed |
|
||||
| a. Bulk |
76741.71
|
69502.59
|
73590.02
|
||
| b. Formulations |
2823.36
|
1975.44
|
2786.11
|
||
| Total |
79565.07
|
71478.03
|
76376.13
|
||
|
|||||
|
|||||